Objective:To explore the effect of Oxymatrine(OMT)on hepatocellular carcinoma cells and its possible action pathways.Methods:The core targets of Oxymatrine action in hepatocellular carcinoma were identified using network pharmacology and validated using in vitro experiments.CCK8 assay and scratch assay were used to detect the effects of Oxymatrine on the proliferation and migration of MHCC97H(TP53 mutant)cells,and Western blot assay and qPcr assay were used to find out the expression of the core targets after Oxymatrine acted on MHCC97H cells at the protein level and mRNA level,respectively.Results:Network pharmacology showed that the core target was TP53 protein;CCK8 assay showed that the IC50 at 24 h and 48 h was 9.64 mg/ml and 7.47 mg/ml,respectively;Scratch assay proved that Oxymatrine markedly inhibited the migratory ability of MHCC97H cells;Western blot assay and qPcr assay found that TP53 gene expression was down-regulated.The western blot experiment and qPcr experiment found that TP53 gene expression was down-regulated.Conclusions:Oxymatrine significantly inhibited the proliferation and migration of hepatocellular carcinoma MHCC97H cells,and its mechanism of action may be related to TP53.
探讨氧化苦参碱(OMT)乳膏对小鼠皮肤屏障功能的修复作用。将70只雄性ICR小鼠随机分为7组,除正常组小鼠外,采用胶带粘贴法模拟机械损伤,复制皮肤屏障功能障碍小鼠模型。造模后经皮连续给药5天,拍摄照片并测定造模区域的经表皮失水量(TEWL)。实验结束后,HE染色观察皮肤组织形态学变化,酶联免疫吸附法(ELISA)检测皮肤组织中肿瘤坏死因子α(TNF-α)、白细胞介素-8(IL-8)的含量,通过实时定量PCR(RT-qPCR)检测紧密连接蛋白(ZO-1)、丝聚蛋白(FLG)、水通道蛋白3(AQP3)mRNA的表达量,通过Western blot检测屏障相关蛋白如封闭蛋白(OCC)、FLG、紧密连接蛋白(Claudin)的表达量。结果显示,与模型组相比,OMT各剂量组均能降低皮肤TEWL,减轻炎症浸润,改善皮肤病理状态,同时高剂组皮肤组织中TNF-α等炎症因子的含量显著降低(P<0.05),ZO-1、FLG m RNA及OCC、FLG、Claudin蛋白的表达显著升高(P<0.05)。因此,OMT具有修复皮肤屏障功能的作用。
本研究以“质量源于设计”(quality by design,QbD)理念为核心,优化氧化苦参碱-黄芪甲苷共载脂质体(oxymatrine-astragaloside IV liposomes,Om-As-Lip)的处方工艺并对其进行放大验证。采用乙醇注入联合pH梯度法制备Om-As-Lip,通过双重风险评估工具、Plackett-Burman设计和Box-Behnken响应面实验对其关键物料属性进行优化,建立设计空间;进一步考察Om-As-Lip的放大工艺,采用单因素试验优化高压匀质的关键工艺参数,并对其终产品进行质量评价。研究结果发现,黄芪甲苷药脂比、胆脂比和混合磷脂比例(氢化大豆卵磷脂∶大豆卵磷脂)是影响Om-As-Lip质量的关键材料属性,Box-Behnken设计建立的回归模型具有良好的预测性,并确定Om-As-Lip的最佳处方为:黄芪甲苷药脂比为1∶40,胆脂比为1∶10,氢化大豆卵磷脂∶大豆卵磷脂为51∶9。设计空间内的胆脂比可控制在1∶12~1∶5,氢化大豆卵磷脂∶大豆卵磷脂比例可控制在1∶7~17∶3。Om-As-Lip高压匀质的最佳压力为600 bar,循环次数为6次,温度为4℃。基于QbD理念制备的Om-As-Lip质量评价符合预期,建立的处方工艺稳定可行,有望为其今后的开发应用奠定实验基础。
使用超高效液相色谱⁃串联质谱仪,采用同位素内标法定量,建立枸杞中苦参碱和氧化苦参碱的测定方法。样品经1.0%磷酸水溶液超声提取,强阳离子固相萃取柱净化,10 mL 5%氨水甲醇溶液洗脱,采用0.1%甲酸水溶液和甲醇为流动相,梯度洗脱,通过T3色谱柱分离,电喷雾离子源正离子扫描模式、多反应监测模式检测。通过考察不同种类提取溶剂、超声时间、固相萃取条件下目标化合物峰面积,确定最优前处理方式。结果表明:苦参碱和氧化苦参碱在0.5~50.0μg/kg范围内呈现良好线性关系,相关系数(R2)均大于0.999。方法检出限0.05μg/kg,定量限0.2μg/kg。低、中、高3个浓度加标回收试验,苦参碱回收率范围在76.3%~90.7%,相对标准偏差(relative standard deviation,RSD)在2.2%~7.4%,氧化苦参碱回收率范围在79.2%~89.0%,RSD在3.1%~6.6%。该方法适用于枸杞中苦参碱和氧化苦参碱检测。
